Search results
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
Digital Journal· 10 hours agomRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes CAMBRIDGE, MA / ACCESSWIRE / May 31, ...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 9 hours agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any...
Thousands of NHS patients to trial new personalised cancer vaccine in ‘landmark moment’
The Independent via Yahoo News· 18 hours agovaccines is finally starting to bear fruit (Rui Vieira/PA Wire) “Using this information, we can...
Thousands of cancer patients to trial personalised vaccines
BBC via Yahoo News· 1 day agoThat jab was created by Moderna, and used the same technology as in their Covid jabs. Moderna and...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 1 day agoThe authors said the findings underscore the need for new boosters. Next week, the Center for...
US poised to invest millions in mRNA bird flu vaccine amid H5N1 scare
The Telegraph via Yahoo News· 1 day agoThe US government is poised to announce a multimillion-dollar investment in mRNA vaccines for H5N1...
COVID Shots Could Use Another Update, Study Suggests
MedPage Today· 3 days agoThe updated monovalent XBB.1.5 COVID-19 vaccines were effective against Omicron subvariants circulating during the most recent respiratory virus season,...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 3 days agoModerna's valuation in depth, urging readers to consider whether its current market price justifies its intrinsic value and future business performance. Founded in 2010 and ...
Moderna's Options Frenzy: What You Need to Know - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoModerna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with ...
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 2 days agoThe stock was down 5.5% Wednesday morning, bringing the stocks losses to 13% since the market closed...